J Korean Ophthalmol Soc.  1979 Mar;20(1):63-67.

Cyclodiathermy Effect on Post-inflammatory Obstructive Glaucoma

Affiliations
  • 1Department of Ophthalmology, Catholic Medical College, Seoul, Korea.

Abstract

The treatment of pest-inflammatory obstructive glaucoma present difficult and anxious problems. In my case, before acute secondary glaucoma attack, in the region of pupil adhesions between the iris and capsule of the lens was about 3/4 of total pupillary zone and goneoscopically mild grade one peripheral anterior synechia was noted about 6 o'clock area of right eye. But intraocular pressure was normal limit. Ten years after binocular chronic anterior uveitis treatment, right eye suddenly developed .acute anterior uveitis signs and symptoms with 60 mmHg(IOTA). After secondary glaucoma with uveitis of right eye developed, uveitis treatment and diamox and oral glycerol was not controlled intracoular pressure: Intracular pressure was over 30 mmHg (IOTA) against medical treatment for two weeks. After medical treatment for two weeks, intracoular pressure was not controlled because of post-inflammatory obstructive glaucoma developed. During the acute inflammatory phase of right eye, where an iridectomy, a transfixation of iris and filtrating operation is thought to be hazardous because of intraocular surgery. I want to control post-inflammatory obstructive glaucoma without intraocular surgery such as iridectomy or filtrating operation. By the method of cyclodiathermy, the ball type electrode was applied to the inferion half sclera along an arc 6 mm to 8 mm from the limbus at about 15 place several millimeter apart. After 4 months of cyclodiathermy applied, intraocular pressure has been about 18 mHg(IOTA) for 3 months and naked visual acuity of right eye is 0.6.


MeSH Terms

Acetazolamide
Electrodes
Glaucoma*
Glycerol
Intraocular Pressure
Iridectomy
Iris
Pupil
Sclera
Telescopes
Uveitis
Uveitis, Anterior
Visual Acuity
Acetazolamide
Glycerol
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr